Daclizumab: A Potential Asthma Therapy?

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 4 Issue: 3 Year: 2010 Page: 214-221
Author(s): Sabina A. Antoniu

Immune Therapy of Multiple Sclerosis - Future Strategies

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 29 Year: 2012 Page: 4489-4497
Author(s): Sven G. Meuth,Kerstin Gobel,Heinz Wiendl

Survey of Latin American Neuroimmunologists on the Treatment of Multiple Sclerosis with Monoclonal Antibodies

Journal: Current Drug Safety
Volume: 10 Issue: 3 Year: 2015 Page: 217-220
Author(s): Yara Dadalti Fragoso

Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 7 Year: 2010 Page: 640-650
Author(s): Corinna Trebst, Elke Voß, Thomas Skripuletz, Martin Stangel

New Immunosuppressants in Clinical Trial

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 2 Issue: 2 Year: 2002 Page: 73-77
Author(s): Vivian C. McAlister

Old Drugs for New: Contemporary Immunosuppressant Development

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 1 Issue: 4 Year: 2004 Page: 381-384
Author(s): Elizabeth Renouf, Vivian C. McAlister

Currently Used Biologic Agents in the Management of Behcet’s Syndrome

Journal: Current Medicinal Chemistry
Volume: 22 Issue: 16 Year: 2015 Page: 1976-1985
Author(s): Caner Saygin,Didem Uzunaslan,Gulen Hatemi

Current and Future Therapies Targeting the Immune System in Multiple Sclerosis

Journal: Current Pharmaceutical Biotechnology
Volume: 15 Issue: 3 Year: 2014 Page: 276-296
Author(s): Verena Loleit,Viola Biberacher,Bernhard Hemmer

Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

Journal: Reviews on Recent Clinical Trials
Volume: 5 Issue: 3 Year: 2010 Page: 179-188
Author(s): James J. Marriott, Paul W. OConnor

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 3-15
Author(s): Rainer Ehling, Thomas Berger, Markus Reindl